Accelerated Approval
Accelerated approval is when regulatory groups (such as the Food and Drug Administration) speed up the process of making a treatment available to patients. This often happens for serious diseases (that either drastically reduce quality of life or are life-threatening) and when the treatment under study provides meaningful benefit that is superior to currently approved treatments or when no other approved treatment exists.
